Post-market follow-up on Stryker spinal devices used in cervical and thoracolumbar fusion for degenerative spine conditions
Official title: Clinical Outcome Measure at Stryker Spine: COMPASS
Run by VB Spine, LLC · NCT06226272 · Data updated 2026-11-12
This PMCF study tests how well and safely Stryker spinal devices perform over two years in adults undergoing cervical or thoracolumbar fusion for degenerative disc disease or degenerative scoliosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5222 (estimated) |
| Sponsor | VB Spine, LLC Industry-sponsored |
| Locations | 7 sites (Jacksonville, Florida and 6 other locations) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | January 29, 2029 |
| Study ends | January 29, 2032 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT06226272 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing cervical or thoracolumbar spinal fusion or deformity correction with a Stryker device, treated per cleared IFUs at participating centers.
✕Probably not a fit
Patients not receiving ongoing follow-up or not using the specified Stryker devices may not obtain benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter study combining prospective and retrospective data collection to follow patients who have had or will have spinal fusion surgery using Stryker devices. The study uses four protocols (one master and three sub-protocols) focusing on cervical, thoracolumbar, and adult spinal deformities, with predefined performance endpoints and radiographic assessments. Safety data are collected throughout the 24-month post-implant period to evaluate long-term outcomes. Principal sites include Mayo Clinic Florida, MaineHealth Neurosurgery and Spine, and Michigan Orthopaedic Surgeons, with lead sponsorship by VB Spine, LLC.
Why it matters
Potential benefit: If successful, the study could provide evidence on long-term safety and performance of Stryker spinal devices in real-world use.
How similar studies have gone: PMCF programs for spinal devices have demonstrated long-term safety and performance in prior post-market follow-up studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details. Exclusion Criteria: • The exclusion criteria are based on the contraindications as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.
Where it's running
-
Mayo Clinic Florida
Jacksonville, Florida, United States Recruiting -
MaineHealth Neurosurgery and Spine
Scarborough, Maine, United States Recruiting -
Michigan Orthopaedic Surgeons
Southfield, Michigan, United States Recruiting -
Cleveland Clinc
Cleveland, Ohio, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting -
Texas Spine & Scoliosis
Austin, Texas, United States Recruiting
Show 1 more location
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Jad G. Khalil, MD — Michigan Orthopaedic Surgeons
- Study coordinator: Mary Majer
- Email: mary.majer@vbspineco.com
- Phone: 866-526-4171
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bone marrow concentrate injection added to lumbar microdiscectomy
This trial tests whether adding a bone marrow aspirate concentrate injection during lumbar microdiscectomy helps adults recover better than surgery alone.
-
IDCT (Intradiscal Cell Therapy) for single-level mild-to-moderate lumbar degenerative disc disease
This will test whether injecting IDCT (rebonuputemcel) into one degenerating lower-back disc can reduce chronic low back pain in adults with mild-to-moderate lumbar degenerative disc disease.
-
Novosis Putty used with transforaminal lumbar interbody fusion for lumbar degenerative disc disease
The trial will test whether using Novosis Putty during transforaminal lumbar interbody fusion helps adults with lumbar degenerative disc disease heal better compared with standard care.
-
Evaluating a new treatment for painful disc degeneration
This study is testing a new non-surgical treatment for people with painful disc degeneration to see if it can help relieve their back pain when other treatments haven't worked.
-
Evaluating a hybrid surgical approach for cervical degenerative disc disease
This study is testing a new combined surgery for people with neck pain from two damaged discs to see if it works better and is safer than traditional surgery.
-
Evaluating LDGraft for lumbar spine surgery
This study is testing a new device called LDGraft to see if it is safe and effective for patients having surgery for lower back problems compared to using human tissue.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.